AICDA and neoplasm: As expected, therefore, the fraction of nc-AID-associated mutations declined sharply at low CCF values, indicating relatively few subclonal mutations, and suggesting that nc-AID was more active at earlier stages of tumour evolution (Fig. 7b; Supplementary Fig. 6).